Find out how to optimise your operations, minimise cost and reduce delivery time. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in global logistics to exchange ideas on best practice and share case studies on innovation within the area.
Following a quarter that featured reports stating that Novartis had dramatically redistributed its cell and gene therapy unit 1 and saw the public focus turn once again to drug price hikes, Pharma IQ brings you the pharma, biotech and life sciences news highlights for Q3 of 2016. Full Article »
Smaller companies face differing challenges in Clinical Trial Supply, but they also have their own unique advantages. We spoke to Ricardo Lima, Head of Pharmaceutical Development at Bial Research & Development about Bial's experiences.He discussses comparator sourcing, forecasting and working in emerging markets in this detailed case study Full Podcast »
On January 11th 2016, the Comité Economique des Produits de Santé (CEPS - Economic Committee for Health Products) signed on the behalf of the French Government a new agreement, the Accord cadre, with Les entreprises du médicament (LEEM - pharmaceutical companies association) on how to set reimbursed drugs prices for the next 3 years. The CEPS is the body that negotiates drug prices with manufacturers. Full Column »
Ahead of the 2016 Lab Informatics Summit, Pharma IQ discussed the subject of data knowledge management with lab informatics and more specifically manufacturing with a selection of experts. Full Whitepaper »